Obesity study probes glucagon tolerance limits
NCT ID NCT02817659
First seen Apr 03, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study aims to understand how well people with obesity tolerate glucagon, a hormone that raises blood sugar. About 20 healthy obese adults will receive increasing doses of glucagon through an IV. Researchers will measure nausea using a questionnaire to find the highest dose that can be given without causing significant discomfort.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Translational Research Institute for Metabolism and Diabetes
Orlando, Florida, 32804, United States
Conditions
Explore the condition pages connected to this study.